NCT00106847View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

683

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

July 31, 2005

Conditions
PsoriasisParapsoriasis
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY